(S)-homoquisqualate acts as a potent, full agonist at the glutamate metabotropic receptor, distinguishing it from quisqualate which exhibits low efficacy.
Answers are grounded in this paper and cite their sources.
Identifies full mGluR agonist for research; leaves open clinical translation or therapeutic testing.
The synthetic quisqualate analogue, (S)-homoquisqualate was examined for activity at the glutamate metabotropic receptor, in relation to its ability to stimulate phosphoinositide hydrolysis in rat pup cerebro-cortical slices. The compound produced a robust increase in hydrolysis (EC50 = 50.2 +/- 1.6 microM), which, in common with responses to quisqualate and (1S,3R)-1-aminocyclopentane-1,3-dicarboxylate ((1S,3R)-ACPD), was antagonized uncompetitively by L-2-amino-3-phosphonopropionate (L-AP3). In contrast to quisqualate which exhibits low efficacy, (S)-homoquisqualate behaves as a full agonist at the metabotropic receptor.
No takes yet. Share an insight, caveat, or question.
Porter et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: